Isabel Ruehl is a former editorial intern at Spectrum. She recently graduated from Columbia Journalism School and, before that, earned an M.Phil. in Health, Medicine and Society from Cambridge University in the United Kingdom.
Isabel Ruehl
Former news intern
Spectrum
From this contributor
‘Science working as it should’: Autism blood signature study earns open post-publication review
Shortly after the study’s publication, experts critiqued it on PubPeer and other online platforms.
‘Science working as it should’: Autism blood signature study earns open post-publication review
By
Isabel Ruehl
10 January 2023 | 5 min read
Whole-genome trove ties new genes, variants to autism
A massive update to the MSSNG dataset gives qualified researchers ready access to explore autism’s genetic architecture on a cloud-based platform.
Whole-genome trove ties new genes, variants to autism
By
Isabel Ruehl
12 December 2022 | 4 min read
Autism incidence in England varies by ethnicity, class, location
High rates of autism are linked to lower socioeconomic status and minority ethnic groups, according to the largest-ever autism incidence study.
Autism incidence in England varies by ethnicity, class, location
By
Isabel Ruehl
6 December 2022 | 5 min read
‘Assembloids’ lay bare autism-linked genes that hamper neuron development
The model enables the study of autism-linked genes at the earliest stages of neural development.
‘Assembloids’ lay bare autism-linked genes that hamper neuron development
By
Isabel Ruehl
30 November 2022 | 4 min read
Lab-grown ‘embryoids’ offer new window into gene-trait relationships
The developmental models have advantages over natural embryos and other synthetic models, such as organoids, but present technical and ethical challenges.
Lab-grown ‘embryoids’ offer new window into gene-trait relationships
By
Isabel Ruehl
26 October 2022 | 4 min read
Explore more from The Transmitter
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
By
Kenneth Harris
9 July 2026 | 9 min read
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.
By
Dalmeet Singh Chawla
8 July 2026 | 5 min read
Diverse autism genes derail common developmental pathways
Multiple genetic mouse models initially show delayed cortical development, but the animals’ molecular trajectories diverge within weeks after birth, a new study finds.
Diverse autism genes derail common developmental pathways
Multiple genetic mouse models initially show delayed cortical development, but the animals’ molecular trajectories diverge within weeks after birth, a new study finds.
By
Holly Barker
8 July 2026 | 5 min read